Swiss National Bank - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$529,162
-47.5%
300,660
-6.4%
0.00%
-100.0%
Q4 2022$1,008,756
-29.7%
321,260
+9.7%
0.00%0.0%
Q3 2022$1,435,000
+18.4%
292,7600.0%0.00%0.0%
Q2 2022$1,212,000
-28.7%
292,7600.0%0.00%0.0%
Q1 2022$1,701,000
-16.0%
292,760
+8.4%
0.00%0.0%
Q4 2021$2,026,000
-16.8%
270,1600.0%0.00%
-50.0%
Q3 2021$2,434,000
-24.2%
270,160
+0.7%
0.00%0.0%
Q2 2021$3,212,000
-6.7%
268,360
-2.3%
0.00%0.0%
Q1 2021$3,441,000
-18.7%
274,660
+1.2%
0.00%
-33.3%
Q4 2020$4,235,000
+65.2%
271,3600.0%0.00%
+50.0%
Q3 2020$2,564,000
+10.6%
271,360
+4.9%
0.00%0.0%
Q2 2020$2,318,000
+61.9%
258,760
+15.1%
0.00%0.0%
Q1 2020$1,432,000
-22.8%
224,860
+1.5%
0.00%0.0%
Q4 2019$1,854,000
-5.3%
221,460
+2.4%
0.00%0.0%
Q3 2019$1,958,000
-13.6%
216,360
+2.9%
0.00%0.0%
Q2 2019$2,266,000
+27.7%
210,360
+13.1%
0.00%0.0%
Q1 2019$1,775,000
-14.0%
186,060
+3.5%
0.00%
-33.3%
Q4 2018$2,064,000
-31.2%
179,760
+1.5%
0.00%0.0%
Q3 2018$3,001,000
+22.0%
177,060
+2.3%
0.00%0.0%
Q2 2018$2,459,000
-11.0%
173,160
+19.1%
0.00%0.0%
Q1 2018$2,762,000
+18.2%
145,360
+2.0%
0.00%0.0%
Q4 2017$2,336,000
+13.6%
142,460
+3.9%
0.00%
+50.0%
Q3 2017$2,056,000
+62.8%
137,060
-4.5%
0.00%
+100.0%
Q2 2017$1,263,000
+113.7%
143,560
+26.4%
0.00%0.0%
Q1 2017$591,000
+70.8%
113,5600.0%0.00%0.0%
Q4 2016$346,000
-34.2%
113,5600.0%0.00%0.0%
Q3 2016$526,000
-20.1%
113,5600.0%0.00%0.0%
Q2 2016$658,000
-0.8%
113,5600.0%0.00%0.0%
Q1 2016$663,000
-21.2%
113,560
+23.2%
0.00%
-50.0%
Q4 2015$841,000
+61.7%
92,1600.0%0.00%
+100.0%
Q3 2015$520,000
-40.7%
92,160
+16.6%
0.00%
-50.0%
Q2 2015$877,000
-29.3%
79,0600.0%0.00%
-33.3%
Q1 2015$1,240,000
+5.8%
79,060
+2.6%
0.00%
-25.0%
Q4 2014$1,172,000
+45.4%
77,060
+3.1%
0.00%
+33.3%
Q3 2014$806,000
-29.4%
74,7600.0%0.00%
-25.0%
Q2 2014$1,142,000
-15.5%
74,7600.0%0.00%
-20.0%
Q1 2014$1,352,000
+75.6%
74,760
+34.9%
0.01%
+66.7%
Q4 2013$770,000
+32.5%
55,4000.0%0.00%
+50.0%
Q3 2013$581,000
+42.4%
55,400
+5.9%
0.00%0.0%
Q2 2013$408,00052,3000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders